OGN vs TTI · P/E 3.4, rev $6.40B vs P/E 170, $1.50B cap
Organon & Co (OGN) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
TTI does not have a complete income-statement cache yet.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the OGN and TTI stock pages for the full models.
Not investment advice.